Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Skin Pharmacol Physiol ; 32(1): 32-42, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30380537

RESUMO

AIM: We evaluated the effects of the incorporation of zinc oxide (ZnO) nanoparticles in a mesoporous matrix, aiming to improve the textural, structural and morphological properties and verify their safety so that they can be applied in sunscreen cosmetics. MATERIALS AND METHODS: ZnO nano-particles were incorporated into an ordered mesoporous silica matrix known as Santa Barbara Amorphous-15 (SBA-15), using post-synthesis methodology. The resulting nanocomposites were characterized using X-ray diffraction, small angle X-ray scattering, N2 adsorption-desorption isotherms, Fourier transform infrared spectroscopy, scanning electron microscopy and predicted in vitro sun protector factor (SPF) estimation. Effectiveness and safety were evaluated by antimicrobial activity, in vitro cell toxicity and non-invasive multi-photon tomography with fluorescence lifetime imaging. RESULTS: The structure of the nanocomposites was similar to that of SBA-15, with little perturbation caused by ZnO incorporation. Nanocomposites had an increased in vitro SPF, reduced cytotoxic activity and favourable antimicrobial properties compared to ZnO. ZnO:SBA-15 nanocomposites exhibited no measurable toxicity when applied to human skin in vivo. CONCLUSION: Due to their suitable physicochemical properties and improved safety compared to bare ZnO nanoparticles, the ZnO:SBA-15 nanocomposites show promise for use in cosmetic applications.


Assuntos
Composição de Medicamentos/métodos , Nanocompostos/administração & dosagem , Dióxido de Silício/administração & dosagem , Absorção Cutânea/efeitos dos fármacos , Protetores Solares/administração & dosagem , Óxido de Zinco/administração & dosagem , Adulto , Animais , Células 3T3 BALB , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Relação Dose-Resposta a Droga , Portadores de Fármacos/administração & dosagem , Portadores de Fármacos/síntese química , Portadores de Fármacos/metabolismo , Combinação de Medicamentos , Humanos , Camundongos , Nanocompostos/química , Dióxido de Silício/síntese química , Dióxido de Silício/metabolismo , Absorção Cutânea/fisiologia , Protetores Solares/síntese química , Protetores Solares/metabolismo , Testes de Toxicidade Aguda/métodos , Difração de Raios X/métodos , Adulto Jovem , Óxido de Zinco/síntese química , Óxido de Zinco/metabolismo
2.
Skin Pharmacol Physiol ; 31(1): 1-9, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29131088

RESUMO

The use of sunscreen products is widely promoted by schools, government agencies, and health-related organizations to minimize sunburn and skin damage. In this study, we developed stable solid lipid nanoparticles (SLNs) containing the chemical UV filter octyl methoxycinnamate (OMC). In parallel, we produced similar stable SLNs in which 20% of the OMC content was replaced by the botanical urucum oil. When these SLNs were applied to the skin of human volunteers, no changes in fluorescence lifetimes or redox ratios of the endogenous skin fluorophores were seen, suggesting that the formulations did not induce toxic responses in the skin. Ex vivo (skin diffusion) tests showed no significant penetration. In vitro studies showed that when 20% of the OMC was replaced by urucum oil, there was no reduction in skin protection factor (SPF), suggesting that a decrease in the amount of chemical filter may be a viable alternative for an effective sunscreen, in combination with an antioxidant-rich vegetable oil, such as urucum. There is a strong trend towards increasing safety of sun protection products through reduction in the use of chemical UV filters. This work supports this approach by producing formulations with lower concentrations of OMC, while maintaining the SPF. Further investigations of SPF in vivo are needed to assess the suitability of these formulations for human use.


Assuntos
Lipídeos/química , Nanopartículas/química , Óleos de Plantas/química , Protetores Solares/química , Química Farmacêutica/métodos , Cinamatos/administração & dosagem , Cinamatos/química , Humanos , Permeabilidade/efeitos dos fármacos , Óleos de Plantas/administração & dosagem , Pele/efeitos dos fármacos , Absorção Cutânea/efeitos dos fármacos , Protetores Solares/administração & dosagem , Raios Ultravioleta/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA